Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-060763

Chief Executive Officer sold 4,400 shares at an average $13.47 ($59,268)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-13 Sale : show line 1 in the form −2,200 $13.53 $29,766 421,978 I
2017-11-14 Sale : show line 2 in the form −2,200 $13.41 $29,502 419,778 I
Open-market sales · 4,400 sh · avg $13.47 · $59,268
Loading xslF345X03/doc4.xml…